( NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced it will present new treatment comparison results evaluating ANKTIVA ® (nogapendekin alfa inbakicept-pmln) plus Bacillus ...

As new therapies emerge, particularly for non-muscle invasive disease, clinicians and patients are faced with increasingly ...

Screening women with dense breasts with both molecular breast imaging (MBI) and digital breast tomosynthesis (DBT) increased overall invasive cancer detection while modestly increasing the recall rate ...

Molecular/genomic profiling is expanding precision selection of systemic therapy and may enable immunotherapy-driven organ ...

Studying a person's genetic makeup can predict if they will go on to develop invasive breast cancer after abnormal cells have been found in their breast tissue. For the first time, researchers at King ...

Melanoma Monday is a day to raise awareness about the invasive skin cancer. However, a recent MedStar Health survey reveals ...

Muscle-invasive bladder cancer (MIBC) has historically been managed with neoadjuvant cisplatin-based chemotherapy followed by radical cystectomy (RC), a strategy associated with substantial morbidity ...

But when Jimi began experiencing bladder cancer symptoms, including blood in his urine, he felt a different kind of rush. It ...

Appointment signals next phase of expansion for HIFU-based prostate care as demand grows for non-invasive, ...